object
present
studi
character
dose
depend
intraven
escherichia
coli
challeng
colostrumf
jersey
calv
identifi
biochem
marker
indic
septicemia
eighteen
old
colostrumf
jersey
calv
complet
random
dose
e
coli
challeng
dose
includ
colonyform
unit
cfu
given
intraven
bolu
ml
steril
isoton
salin
peripher
blood
sampl
collect
h
rel
challeng
biochem
total
leukocyt
count
differenti
analys
rectal
temperatur
collect
via
indwel
rectal
temperatur
probe
interv
hourli
averag
calcul
prior
challeng
till
challeng
calv
surviv
h
observ
period
follow
challeng
calv
given
cfu
display
sick
behavior
p
begin
h
challeng
return
control
calv
h
calv
challeng
cfu
respect
treatment
time
interact
p
total
leukocyt
count
plasma
glucos
zinc
concentr
calv
administ
cfu
leucopenia
begin
h
challeng
return
count
similar
control
calv
within
h
addit
calv
hypoglycem
h
challeng
degre
hypoglycemia
invers
relat
dose
e
coli
calv
challeng
e
coli
decreas
plasma
zinc
concentr
magnitud
invers
proport
challeng
dose
treatment
time
interact
p
rectal
temperatur
follow
challeng
calv
challeng
e
coli
develop
febril
respons
intens
durat
respons
depend
challeng
dose
data
indic
calv
intraven
challeng
cfu
e
coli
show
immedi
clinic
biochem
sign
indic
septicemia
howev
calv
administ
less
e
coli
febril
respons
develop
septicemia
blood
glucos
zinc
concentr
may
dose
respons
indic
could
potenti
differenti
septicem
versu
nonsepticem
calf
object
present
studi
character
dose
depend
intraven
escherichia
coli
challeng
colostrumf
jersey
calv
identifi
biochem
marker
indic
septicemia
eighteen
old
colostrumf
jersey
calv
complet
random
dose
e
coli
challeng
dose
includ
colonyform
unit
cfu
given
intraven
bolu
ml
steril
isoton
salin
peripher
blood
sampl
collect
h
rel
challeng
biochem
total
leukocyt
count
differenti
analys
rectal
temperatur
collect
via
indwel
rectal
temperatur
probe
interv
hourli
averag
calcul
prior
challeng
till
challeng
calv
surviv
h
observ
period
follow
challeng
calv
given
cfu
display
sick
behavior
p
begin
h
challeng
return
control
calv
h
calv
challeng
cfu
respect
treatment
time
interact
p
total
leukocyt
count
plasma
glucos
zinc
concentr
calv
administ
cfu
leucopenia
begin
h
challeng
return
count
similar
control
calv
within
h
addit
calv
hypoglycem
h
challeng
degre
hypoglycemia
invers
relat
dose
e
coli
calv
challeng
e
coli
decreas
plasma
zinc
concentr
magnitud
invers
proport
challeng
dose
treatment
time
interact
p
rectal
temperatur
follow
challeng
calv
challeng
e
coli
develop
febril
respons
intens
durat
respons
depend
challeng
dose
data
indic
calv
intraven
challeng
cfu
e
coli
show
immedi
clinic
biochem
sign
indic
septicemia
howev
calv
administ
less
e
coli
febril
respons
develop
septicemia
blood
glucos
zinc
concentr
may
dose
respons
indic
could
potenti
differenti
septicem
versu
nonsepticem
calf
elsevi
bv
right
reserv
well
document
dairi
calv
highli
suscept
diseas
earli
mortal
roy
enter
diseas
primari
caus
prewean
morbid
mortal
mani
enter
pathogen
caus
bacteremia
septicemia
among
dairi
calv
thirtyon
percent
scour
calv
bacterem
surviv
rate
low
lofstedt
et
al
agreement
fecteau
et
al
experi
observ
sever
ill
calv
bacterem
mortal
blood
cultur
posit
calv
greater
versu
blood
cultur
neg
calv
fecteau
et
al
report
bacteri
isol
escherichia
coli
gram
neg
enter
gram
neg
anaerob
gram
posit
cocci
gram
posit
rod
high
mortal
blood
cultur
bacteria
posit
calv
could
associ
septic
shock
due
overaggress
system
acut
phase
respons
system
releas
proinflammatori
mediat
tumor
necrosi
respons
bacteri
deriv
immunogen
caus
vasodil
increas
vascular
permeabl
activ
clot
cascad
decreas
perfus
blood
mani
vital
organ
lead
irrevers
organ
damag
consequ
death
immedi
administr
antibiot
therapeut
treatment
would
need
implement
septicem
calf
howev
differenti
septicem
nonsepticem
calf
scour
difficult
base
clinic
observ
alon
fecteau
et
al
need
inexpens
rapid
onfarm
test
accur
precis
identifi
septicem
calv
object
present
studi
character
pathogenesi
septicemia
colostrumf
jersey
calv
identifi
potenti
biochem
marker
indic
septicemia
anim
care
conduct
accord
guid
care
use
agricultur
anim
agricultur
research
teach
approv
institut
anim
care
use
committe
usdaar
twenti
jersey
bull
calv
age
acquir
local
commerci
dairi
januari
transport
km
livestock
issu
research
unit
calf
facil
liberti
tx
calv
given
quart
pool
colostrum
within
first
h
life
cow
herd
routin
vaccin
rotaviru
coronaviru
lipopolysaccharid
lp
core
antigen
e
coli
peripher
blood
sampl
collect
immedi
upon
arriv
serum
collect
quantifi
total
serum
protein
use
temperatur
control
refractomet
atago
inc
bellevu
wa
antibodi
lp
core
antigen
could
attenu
respons
current
studi
compar
calv
receiv
colostrum
cow
vaccin
lp
core
antigen
receiv
colostrum
deluyk
et
al
calv
individu
hous
stainless
steel
pen
slot
rubber
mat
floor
thermocontrol
room
rang
c
calf
nurseri
illumin
fluoresc
light
h
day
calv
fed
gd
asf
commerci
nonmed
fat
milk
protein
milk
replac
lawley
inc
stockton
ca
adapt
period
period
calv
scour
treat
therapeut
acidifi
oral
electrolyt
bluelit
c
tech
mix
stewart
mn
bismuth
subsalicyl
ad
directli
milk
replac
calv
fed
twice
daili
h
calv
fit
indwel
rectal
temperatur
probe
reuter
et
al
rectal
temperatur
probe
consist
dst
microt
small
thermo
logger
star
oddi
reykjavik
iceland
enclos
mm
outsid
diamet
mm
long
stainless
steel
fabric
capsul
attach
mm
outsid
diamet
mm
long
pvc
tube
pvc
tube
attach
half
fabric
piec
powderco
aluminum
pipe
mm
long
mm
intern
diamet
secur
tail
use
coflex
flexibl
bandag
andov
healthcar
andov
rectal
temperatur
collect
via
dst
microt
small
thermo
logger
interv
hourli
averag
calcul
h
prior
challeng
till
h
challeng
prior
one
calf
die
eighteen
remain
calv
complet
random
intraven
treatment
dose
e
coli
e
coli
express
intimin
shigalik
toxin
gene
challeng
dose
includ
colonyform
unit
cfu
given
bolu
venapunctur
ml
steril
isoton
salin
immedi
follow
feed
challeng
dose
prepar
h
loggrowth
cultur
tryptic
soy
broth
briefli
ml
tryptic
soy
broth
inocul
pure
cultur
e
coli
microbank
bead
prolab
diagnost
austin
tx
cultur
incub
h
c
rpm
quantiti
free
lp
determin
duplic
cultur
grown
condit
use
challeng
cultur
commerci
laboratori
nelson
laboratori
salt
lake
citi
ut
use
limulu
amebocyt
lysat
method
confirm
challeng
dose
perform
approxim
min
challeng
administ
spread
plate
serial
dilut
rang
e
coli
challeng
dose
base
data
smith
hall
old
calv
use
current
studi
ensur
calv
free
clinic
sign
enter
system
diseas
addit
h
observ
period
evalu
base
clinic
cours
diseas
observ
smith
hall
variou
challeng
strain
e
coli
administ
intraven
e
coli
strain
chosen
present
studi
lab
use
phagocyt
oxid
burst
assay
shown
rapidli
phagocyt
produc
robust
oxid
burst
hulbert
et
al
display
sick
behavior
assess
min
interv
h
hourli
till
h
final
h
rel
challeng
singl
blind
observ
behavior
classifi
normal
alert
respons
stimuli
quick
depress
respons
stimuli
decreas
letharg
respons
stimuli
greatli
reduc
morbid
littl
respons
stimuli
attitud
data
collect
observ
ten
ml
peripher
blood
collect
venapunctur
h
rel
challeng
heparin
vacutain
leukocyt
differenti
count
analys
follow
leukocyt
differenti
analys
whole
blood
centrifug
g
min
plasma
remov
store
c
biochem
analys
within
min
blood
collect
whole
blood
analys
total
leukocyt
count
differenti
analys
neutrophil
mononuclear
cell
use
cell
dyn
abbot
laboratori
abbott
il
set
cell
dyne
bovin
blood
differenti
mononuclear
cell
lymphocyt
monocyt
therefor
lymphocyt
count
encompass
lymphocyt
monocyt
plasma
glucos
urea
nitrogen
analys
use
commerci
avail
enzymat
kit
stanbio
laboratori
boern
tx
procedur
follow
per
manufactur
instruct
manual
method
except
reduc
sampl
reagent
volum
use
micropl
method
absorb
measur
spectramax
molecular
devic
sunnyval
ca
control
serum
randox
laboratori
jefferson
citi
wv
use
calcul
interassay
coeffici
variat
plasma
glucos
urea
nitrogen
respect
intraassay
coeffici
variat
plasma
glucos
urea
nitrogen
respect
plasma
cytokin
tumor
necrosi
measur
use
multiplex
sandwichbas
chemiluminesc
elisa
searchlightaushon
biosystem
inc
billerica
interand
intraassay
coeffici
variat
respect
plasma
haptoglobin
quantifi
describ
makimura
suzuki
interand
intraassay
coeffici
variat
haptoglobin
assay
respect
plasma
zinc
concentr
analys
atom
absorpt
spectrometri
smimadzu
columbia
md
plasma
protein
precipit
mix
equal
volum
plasma
trichloroacet
acid
incub
c
min
intraand
interassay
coeffici
variat
respect
repeat
continu
data
analys
restrict
maximum
likelihood
anova
complet
random
design
use
mix
procedur
sa
version
sa
institut
cari
nc
linear
mix
model
fix
effect
treatment
time
interact
treatment
time
fit
mean
biochem
measur
h
mean
rectal
temperatur
h
rel
e
coli
challeng
use
covari
model
mix
model
run
avail
covari
structur
withinsubject
measur
appropri
covari
structur
effect
intraven
e
coli
challeng
dose
sick
score
lsmean
sem
colonyform
unit
treatment
time
p
slice
time
effect
report
p
unequ
space
chosen
base
schwarz
bayesian
inform
criterion
sick
score
data
analys
gener
estim
equat
poisson
distribut
use
genmod
procedur
sa
calf
repeat
unit
exchang
covari
structur
use
fit
data
mean
separ
perform
time
signific
treatment
time
interact
use
slicedeffect
multipl
comparison
approach
tukeykram
adjust
version
sa
institut
cari
nc
least
squar
mean
report
throughout
treatment
differ
p
consid
statist
signific
p
consid
tendenc
calf
total
serum
protein
concentr
greater
ml
serum
protein
concentr
averag
ml
quantiti
free
endotoxin
g
variat
calv
challeng
cfu
express
per
kg
bw
calv
receiv
approxim
g
free
lpskg
bw
calv
challeng
either
cfu
bolu
iv
develop
sick
behavior
within
min
post
challeng
p
fig
acut
respons
first
h
dose
depend
wherea
cfu
challeng
calv
sever
respons
behavior
continu
alter
h
postchalleng
calv
challeng
cfu
sick
behavior
return
normal
within
h
postchalleng
wherea
calv
challeng
cfu
show
mild
sign
sick
behavior
h
postchalleng
final
calv
challeng
either
cfu
show
sign
sick
h
postchalleng
observ
period
calv
challeng
either
cfu
elev
peripher
proinflammatori
cytokin
concentr
fig
b
elev
concentr
statist
signific
like
due
sampl
frequenc
current
studi
dose
depend
respons
p
concentr
wherea
calv
challeng
cfu
greater
magnitud
persist
respons
calv
challeng
cfu
fig
calv
challeng
cfu
less
concentr
either
proinflammatori
cytokin
baselin
time
follow
challeng
peripher
concentr
elev
calv
except
challeng
challeng
cfu
fig
concentr
peak
p
calv
challeng
four
h
postchalleng
return
baselin
h
concentr
began
increas
dose
h
postchalleng
return
back
baselin
h
furthermor
calv
challeng
intermedi
dose
e
coli
cfu
greatest
respons
h
postchalleng
acut
leucopenia
within
h
postchalleng
observ
p
calv
administ
either
cfu
persist
h
postchalleng
fig
calv
challeng
cfu
develop
mild
leucopenia
h
postchalleng
treatment
time
interact
percentag
circul
neutrophil
p
howev
individu
treatment
peripher
neutrophil
percentag
highli
variabl
fig
calv
challeng
cfu
reduc
percentag
peripher
neutrophil
h
postchalleng
wherea
calv
challeng
cfu
increas
percentag
neutrophil
circul
h
postchalleng
addit
calv
challeng
cfu
increas
percentag
h
postchalleng
acut
hypoglycemia
observ
p
calv
administ
either
cfu
return
baselin
concentr
h
postchalleng
fig
effect
intraven
e
coli
dose
concentr
plasma
urea
nitrogen
data
shown
twelv
h
postchalleng
plasma
haptoglobin
concentr
increas
p
calv
challeng
cfu
tend
p
also
elev
h
postchalleng
fig
h
postchalleng
calv
administ
intermedi
dose
e
coli
cfu
greatest
increas
p
plasma
haptoglobin
concentr
h
postchalleng
calv
administ
elev
p
haptoglobin
concentr
plasma
zinc
concentr
decreas
p
calv
challeng
e
coli
fig
magnitud
effect
intraven
e
coli
challeng
dose
plasma
concentr
lsmean
sem
colonyform
unit
treatment
time
p
slice
time
effect
report
p
p
c
effect
intraven
e
coli
challeng
dose
plasma
concentr
lsmean
sem
colonyform
unit
treatment
time
p
slice
time
effect
report
p
denot
multipl
treatment
particular
signific
time
rel
challeng
hr
colonyform
unit
treatment
time
p
slice
time
effect
report
p
p
denot
multipl
treatment
particular
signific
b
effect
intraven
e
coli
challeng
dose
percentag
peripher
blood
neutrophil
lsmean
sem
colonyform
unit
treatment
time
p
slice
time
effect
report
p
decreas
plasma
zinc
invers
proport
challeng
dose
calv
challeng
intraven
e
coli
develop
febril
respons
p
fig
calv
challeng
lower
dose
e
coli
cfu
febril
respons
persist
h
h
postchalleng
respect
calv
challeng
intermedi
dose
cfu
greatest
peak
febril
respons
peak
h
postchalleng
calv
challeng
greater
equal
cfu
febril
respons
persist
h
postchalleng
dose
respons
impact
intraven
e
coli
challeng
pathogenesi
diseas
colonyform
unit
treatment
time
p
slice
time
effect
report
p
b
effect
intraven
e
coli
challeng
dose
concentr
plasma
haptoglobin
lsmean
sem
treatment
time
p
treatment
p
slice
time
effect
report
p
p
colonyform
unit
treatment
time
p
slice
time
effect
p
interv
report
state
colostrum
fed
jersey
calv
investig
largest
dose
e
coli
use
studi
induc
acut
sign
septicemia
includ
sick
behavior
febril
respons
increas
peripher
proinflammatori
cytokin
hypoglycemia
leucopenia
mani
respons
dose
depend
calv
challeng
cfu
display
sever
depress
behavior
calv
challeng
cfu
becam
recumb
calv
reaction
stimuli
peak
respons
greatest
score
sick
behavior
among
calv
treat
two
highest
dose
occur
h
postchalleng
calv
began
recov
calv
challeng
cfu
recov
within
h
latenc
recoveri
calv
challeng
cfu
longer
occur
within
h
smith
hall
also
observ
immedi
sick
behavior
colostrum
depriv
adequ
jersey
calv
challeng
intraven
cfu
e
coli
persist
h
postchalleng
current
studi
hypoglycemia
sever
calv
challeng
cfu
challeng
cfu
dose
depend
clinic
biochem
respons
endotoxin
observ
cattl
depend
respons
variabl
jacobsen
et
al
evid
current
studi
magnitud
tempor
respons
leucopenia
similar
calv
challeng
either
two
high
dose
e
coli
acut
respons
observ
anim
similar
observ
jersey
calv
challeng
purifi
lp
howev
febril
respons
sustain
h
postchalleng
use
live
pathogen
wherea
rectal
temperatur
jersey
calv
return
baselin
within
h
lp
challeng
previou
studi
ballou
et
al
probabl
acut
sign
septicemia
calv
challeng
either
cfu
least
partial
attribut
concentr
free
lp
challeng
prepar
twelv
h
postchalleng
calv
challeng
cfu
display
depress
sick
behavior
correspond
peak
rectal
temperatur
mild
leucopenia
nadir
plasma
zinc
concentr
calv
challeng
cfu
greatest
peak
rectal
temperatur
occur
h
postchalleng
greater
magnitud
febril
respons
observ
calv
may
occur
respons
attenu
counter
antiinflammatori
respons
robust
counter
antiinflammatori
respons
often
observ
endotoxemia
septicemia
ejima
et
al
although
calv
challeng
either
cfu
display
sick
behavior
chang
leucocyt
biochem
respons
h
postchalleng
observ
period
develop
dosedepend
febril
decreas
plasma
zinc
concentr
respons
calv
challeng
cfu
display
slight
febril
respons
h
postchalleng
wherea
calv
challeng
cfu
febril
respons
greater
magnitud
length
last
h
postchalleng
data
indic
calv
challeng
less
equal
cfu
develop
acut
phase
respons
becom
septicem
could
reflect
good
colostrum
statu
calv
e
coli
use
current
studi
data
also
indic
rectal
temperatur
plasma
zinc
concentr
sensit
indic
infect
necessarili
specif
septicemia
proinflammatori
cytokin
acut
elev
calv
challeng
largest
dose
cfu
e
coli
peripher
inflamm
septicemia
endotoxemia
directli
activ
central
nervou
system
alter
thermoregulatori
center
brain
givaloi
et
al
howev
local
inflamm
febril
respons
still
observ
even
absenc
peripher
proinflammatori
cytokin
zhang
et
al
current
data
indic
febril
decreas
plasma
zinc
concentr
respons
infect
without
concurr
septicemia
independ
peripher
concentr
proinflammatori
cytokin
addit
leucopenia
increas
plasma
haptoglobin
concentr
calv
challeng
cfu
influenc
peripher
cytokin
concentr
contrast
well
document
rat
human
acut
phase
protein
synthesi
respons
proinflammatori
cytokin
koj
gabay
et
al
furthermor
consid
major
induc
acut
phase
protein
synthesi
heinrich
et
al
despit
elev
haptoglobin
observ
h
postchalleng
cfu
challeng
calv
current
data
indic
intermedi
dose
e
coli
cfu
greatest
sustain
increas
plasma
haptoglobin
local
inflamm
peripher
factor
measur
current
studi
may
influenc
respons
greater
respons
observ
calv
challeng
cfu
could
due
less
acut
counter
antiinflammatori
respons
like
observ
calv
challeng
either
cfu
peripher
concentr
elev
calv
challeng
greater
equal
cfu
howev
respons
dose
depend
calv
challeng
cfu
acut
respons
greatest
elev
h
previou
research
laboratori
shown
concentr
plasma
increas
follow
intraven
lp
challeng
among
beef
calv
peak
h
return
baselin
concentr
within
h
carrol
et
al
concentr
plasma
jersey
calv
challeng
cfu
approxim
fold
higher
observ
carrol
et
al
versu
pgml
current
data
taken
togeth
data
carrol
et
al
suggest
immunogen
live
cultur
stimul
secret
addit
observ
lp
alon
sourc
measur
plasma
unknown
could
either
come
direct
stimul
natur
killer
cell
activ
tlymphocyt
addit
calv
challeng
cfu
display
clinic
hematolog
biochem
respons
indic
septicemia
differ
tempor
respons
peak
h
return
baselin
within
h
post
challeng
observ
calv
challeng
either
cfu
purifi
lp
carrol
et
al
tempor
respons
observ
calv
challeng
cfu
similar
calv
challeng
either
cfu
delay
cytokin
respons
observ
among
calv
like
reflect
link
innat
adapt
immun
respons
secret
natur
killer
cell
rule
similar
tempor
result
observ
rat
challeng
streptococcu
pneumonia
furthermor
use
knockout
abl
show
protect
role
rubin
pomeroy
final
identifi
sensit
specif
biochem
marker
use
farm
identifi
sever
ill
calf
either
septicem
nonsepticem
would
help
determin
appropri
therapeut
treatment
hypoglycemia
leucopenia
decreas
plasma
miner
concentr
calv
follow
lp
challeng
consist
report
kinsbergen
et
al
deluyk
et
al
ballou
et
al
current
data
suggest
plasma
glucos
zinc
mayb
doserespons
indic
acut
e
coli
septicemiaendotoxemia
diagnost
valu
use
either
plasma
glucos
zinc
concentr
identifi
calf
septicem
versu
nonsepticem
calf
scour
unknown
futur
research
determin
sensit
specif
metabolit
screen
sever
ill
calv
septicemia
plausibl
nonsepticem
calv
scour
could
also
decreas
plasma
glucos
andor
zinc
concentr
due
decreas
absorpt
nutrient
conclus
calv
challeng
cfu
e
coli
rapidli
develop
sign
septicemiaendotoxemia
degre
hypoglycemia
decreas
plasma
zinc
observ
directli
relat
challeng
dose
calv
challeng
intermedi
dose
cfu
develop
robust
acut
phase
respons
stronger
febril
respons
sustain
acut
phase
protein
synthesi
howev
acut
phase
respons
calv
independ
increas
peripher
concentr
either
proinflammatori
cytokin
calv
develop
febril
respons
indic
rectal
temperatur
sensit
measur
infect
nonspecif
degre
infect
jersey
calv
fed
colostrum
surviv
h
follow
e
coli
challeng
